Honghe Fujie Lotion for the Treatment of Bacterial Vaginosis
Status:
Unknown status
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
This is a Randomized, Positive -Controlled, Multi-center Trial enrolling 240 subjects with
Bacterial Vaginosis who will be randomized at a ratio of 1:1 to receive active Honghe Fujie
lotion or Metronidazole Suppositories. The primary objective is to assess the safety and
tolerability of Honghe Fujie lotion compared to Metronidazole Suppositories.
Phase:
Phase 4
Details
Lead Sponsor:
Dongfang Hospital Affiliated to Beijing University of Chinese Medicine Dongfang Hospital Beijing University of Chinese Medicine
Collaborators:
Beijing Compete Pharmaceutical Co., Ltd. Peking University First Hospital Shandong Buchang Pharmaceutical Co., Ltd.